175 related articles for article (PubMed ID: 32392410)
1. Antibody Subunit LC-MS Analysis for Pharmacokinetic and Biotransformation Determination from In-Life Studies for Complex Biotherapeutics.
Kellie JF; Pannullo KE; Li Y; Fraley K; Mayer A; Sychterz CJ; Szapacs ME; Karlinsey MZ
Anal Chem; 2020 Jun; 92(12):8268-8277. PubMed ID: 32392410
[TBL] [Abstract][Full Text] [Related]
2. Biotherapeutic Antibody Subunit LC-MS and Peptide Mapping LC-MS Measurements to Study Possible Biotransformation and Critical Quality Attributes In Vivo.
Kellie JF; Thomson AS; Chen S; Childs SL; Karlinsey MZ; Mai SH; White JR; Biddlecombe RA
J Pharm Sci; 2019 Apr; 108(4):1415-1422. PubMed ID: 30465782
[TBL] [Abstract][Full Text] [Related]
3. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.
Qu M; An B; Shen S; Zhang M; Shen X; Duan X; Balthasar JP; Qu J
Mass Spectrom Rev; 2017 Nov; 36(6):734-754. PubMed ID: 27097288
[TBL] [Abstract][Full Text] [Related]
4. Custom-Designed Affinity Capture LC-MS F(ab')2 Assay for Biotransformation Assessment of Site-Specific Antibody Drug Conjugates.
Su D; Ng C; Khosraviani M; Yu SF; Cosino E; Kaur S; Xu K
Anal Chem; 2016 Dec; 88(23):11340-11346. PubMed ID: 27779866
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Antibody-Drug Conjugate Pharmacokinetics and in Vivo Biotransformation Using Quantitative Intact LC-HRMS and Surrogate Analyte LC-MRM.
Huang Y; Mou S; Wang Y; Mu R; Liang M; Rosenbaum AI
Anal Chem; 2021 Apr; 93(15):6135-6144. PubMed ID: 33835773
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates.
Kamath AV; Iyer S
Pharm Res; 2015 Nov; 32(11):3470-9. PubMed ID: 25446773
[TBL] [Abstract][Full Text] [Related]
7. Universal Affinity Capture Liquid Chromatography-Mass Spectrometry Assay for Evaluation of Biotransformation of Site-Specific Antibody Drug Conjugates in Preclinical Studies.
Kotapati S; Passmore D; Yamazoe S; Sanku RKK; Cong Q; Poudel YB; Chowdari NS; Gangwar S; Rao C; Rangan VS; Cardarelli PM; Deshpande S; Strop P; Dollinger G; Rajpal A
Anal Chem; 2020 Jan; 92(2):2065-2073. PubMed ID: 31860282
[TBL] [Abstract][Full Text] [Related]
8. Conjugation Site Influences Antibody-Conjugated Drug PK Assays: Case Studies for Disulfide-Linked, Self-Immolating Next-Generation Antibody Drug Conjugates.
Lee MV; Kaur S; Saad OM
Anal Chem; 2020 Sep; 92(18):12168-12175. PubMed ID: 32786429
[TBL] [Abstract][Full Text] [Related]
9. Intact Protein Mass Spectrometry for Therapeutic Protein Quantitation, Pharmacokinetics, and Biotransformation in Preclinical and Clinical Studies: An Industry Perspective.
Kellie JF; Tran JC; Jian W; Jones B; Mehl JT; Ge Y; Henion J; Bateman KP
J Am Soc Mass Spectrom; 2021 Aug; 32(8):1886-1900. PubMed ID: 32869982
[TBL] [Abstract][Full Text] [Related]
10. Catabolism of antibody drug conjugates and characterization methods.
Shadid M; Bowlin S; Bolleddula J
Bioorg Med Chem; 2017 Jun; 25(12):2933-2945. PubMed ID: 28438386
[TBL] [Abstract][Full Text] [Related]
11. Bioanalytical methods for therapeutic monoclonal antibodies and antibody-drug conjugates: A review of recent advances and future perspectives.
Todoroki K; Mizuno H; Sugiyama E; Toyo'oka T
J Pharm Biomed Anal; 2020 Feb; 179():112991. PubMed ID: 31761377
[TBL] [Abstract][Full Text] [Related]
12. Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology.
Roberts SA; Andrews PA; Blanset D; Flagella KM; Gorovits B; Lynch CM; Martin PL; Kramer-Stickland K; Thibault S; Warner G
Regul Toxicol Pharmacol; 2013 Dec; 67(3):382-91. PubMed ID: 24012707
[TBL] [Abstract][Full Text] [Related]
13. Native-MS Analysis of Monoclonal Antibody Conjugates by Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
Campuzano IDG; Netirojjanakul C; Nshanian M; Lippens JL; Kilgour DPA; Van Orden S; Loo JA
Anal Chem; 2018 Jan; 90(1):745-751. PubMed ID: 29193956
[TBL] [Abstract][Full Text] [Related]
14. High-Resolution Characterization of ADCs by Orbitrap LCMS.
He J; Kaur S; Xu K
Methods Mol Biol; 2020; 2078():213-219. PubMed ID: 31643059
[TBL] [Abstract][Full Text] [Related]
15. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
[TBL] [Abstract][Full Text] [Related]
16. [Bioanalysis in the development of antibody-drug conjugates].
Li XL; Chen XY; Zhong DF
Yao Xue Xue Bao; 2016 Apr; 51(4):517-28. PubMed ID: 29859519
[TBL] [Abstract][Full Text] [Related]
17. Bioanalytical Challenges in Support of Complex Modalities of Antibody-Based Therapeutics.
Zhu L; Glick J; Flarakos J
AAPS J; 2020 Oct; 22(6):130. PubMed ID: 33037499
[TBL] [Abstract][Full Text] [Related]
18. PK assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine.
Dere R; Yi JH; Lei C; Saad OM; Huang C; Li Y; Baudys J; Kaur S
Bioanalysis; 2013 May; 5(9):1025-40. PubMed ID: 23641694
[TBL] [Abstract][Full Text] [Related]
19. Intact mAb LC-MS for drug concentration from pre-clinical studies: bioanalytical method performance and in-life samples.
Kellie JF; Alelyunas YW; Albert J; Schneck NA; Chen Z; Sychterz CJ; Edwards I; Shion H; Wrona MD; Szapacs ME
Bioanalysis; 2020 Oct; 12(19):1389-1403. PubMed ID: 32975433
[No Abstract] [Full Text] [Related]
20. Simultaneous analysis of multiple monoclonal antibody biotherapeutics by LC-MS/MS method in rat plasma following cassette-dosing.
Li H; Ortiz R; Tran LT; Salimi-Moosavi H; Malella J; James CA; Lee JW
AAPS J; 2013 Apr; 15(2):337-46. PubMed ID: 23233266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
